{"count": 1, "results": [{"_id": "32951988", "pmid": 32951988, "title": "The suggested chemopreventive association of metformin with prostate cancer in diabetic patients.", "journal": "Urol Oncol", "authors": ["Goldberg H", "Mohsin FK", "Berlin A", "Chandrasekar T", "Wallis CJD", "Klaassen Z", "Ahmad AE", "Saskin R", "Kenk M", "Saarela O", "Kulkarni GS", "Alibhai SMH", "Fleshner N"], "date": "2021-03-01T00:00:00Z", "doi": "10.1016/j.urolonc.2020.08.032", "meta_date_publication": "2021 Mar", "meta_volume": "39", "meta_issue": "3", "meta_pages": "191.e17-191.e24", "score": 50271.508, "text_hl": "CONCLUSION: @SPECIES_9606 @@@Men@@@ receiving @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ were less likely to have suspected or diagnosed @<m>DISEASE_Cap_Myopathy</m> @DISEASE_MESH:C579969 @@@CaP@@@, and in those with @<m>DISEASE_Cap_Myopathy</m> @DISEASE_MESH:C579969 @@@CaP@@@, the use of ADT was less common. ", "citations": {"NLM": "Goldberg H, Mohsin FK, Berlin A, Chandrasekar T, Wallis CJD, Klaassen Z, Ahmad AE, Saskin R, Kenk M, Saarela O, Kulkarni GS, Alibhai SMH, Fleshner N. The suggested chemopreventive association of metformin with prostate cancer in diabetic patients. Urol Oncol. 2021 Mar;39(3):191.e17-191.e24. PMID: 32951988", "BibTeX": "@article{32951988, title={The suggested chemopreventive association of metformin with prostate cancer in diabetic patients.}, author={Goldberg H and Mohsin FK and Berlin A and Chandrasekar T and Wallis CJD and Klaassen Z and Ahmad AE and Saskin R and Kenk M and Saarela O and Kulkarni GS and Alibhai SMH and Fleshner N}, journal={Urol Oncol}, volume={39}, number={3}, pages={191.e17-191.e24}}"}}]}